Interventional Cardiology Market Size, Share & COVID19 Impact Analysis - Global - 2023-2029 - MedSuite - Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more

Interventional Cardiology Market Size, Share & COVID19 Impact Analysis - Global - 2023-2029 - MedSuite - Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more


In 2022, the Global Interventional Cardiology Market was valued at $11 billion. Over the forecast period, it is projected to grow at a CAGR of 2.4% and reach $13 billion.

The comprehensive report suite on the global interventional cardiology market includes various segments such as coronary stent, coronary balloon catheter, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, atherectomy and intravascular lithotripsy (IVL) device, coronary introducer sheath, coronary vascular closure device (VCD), diagnostic catheter and guidewire, optical coherence tomography (OCT) catheter, and intravascular ultrasound (IVUS) catheter markets.

DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Interventional Cardiology Procedure Volumes
Market Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Global Interventional Cardiology market
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
COVID19 Impact on the Global Interventional Cardiology market
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL INTERVENTIONAL CARDIOLOGY MARKET INSIGHTS

Access to healthcare and the development of hospital infrastructure in developing countries across Latin America and Asia-Pacific, including China and India, have shown significant improvement. As a result, more individuals worldwide are able to undergo interventional procedures, leading to the expansion of the device market. The forecasted trend for the future indicates a continuous decline in prices, primarily influenced by market consolidation and bundling practices. With numerous competitors in the market, it has become common for devices to be bundled together at a lower price in order to boost overall sales. The utilization of intravascular imaging technologies varies across different regions worldwide. Currently, North America and Asia Pacific exhibit the highest adoption rates, demonstrating widespread usage of these devices. In contrast, other regions are experiencing a gradual yet steady increase in the implementation of this technology.

GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE INSIGHT

In 2022, three major players, namely Boston Scientific, Abbott, and Medtronic, dominated the global interventional cardiology market. Boston Scientific emerged as the leader in several segments, including coronary stents, balloon catheters, and embolic protection devices. The company's extensive range of devices, coupled with its international sales team, enabled it to maintain its dominant position.

Abbott excelled in the interventional coronary guidewire and OCT catheter markets, particularly in Western Europe. The Xience™ drug-eluting stent, known for its effectiveness in chronic total occlusion (CTO) cases, gained significant traction in terms of units sold.

Medtronic showcased its presence across multiple market segments, including coronary stents, balloon catheters, interventional coronary catheters, diagnostic catheters and guidewires, as well as embolic protection devices and coronary introducer sheaths. The company's notable performance was observed in the interventional coronary catheter market, where it offered product lines such as Launcher®, Sherpa NX™ Active, Sherpa NX™ Balanced, and Telescope™ under its portfolio.

REPORT GEOGRAPHIC COVERAGE

Throughout this research series, iData Research has extensively examined and analyzed several regions. The regions covered in our research include:

North America (United States and Canada)
Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
Central and Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
Africa( South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

DETAILED MARKET SEGMENTATION

While the MedSuite report provides comprehensive analysis and data for the Global Interventional Cardiology Devices market, we also offer individual MedCore reports for each market segment. This allows you to access specific market research that is relevant to your needs.

Coronary Stent Market – MedCore
Coronary Balloon Catheter Market – MedCore
Interventional Coronary Catheter Market – MedCore
Interventional Coronary Guidewire Market – MedCore
Coronary Embolic Protection Device Market – MedCore
Coronary Atherectomy & Intravascular Lithotripsy (IVL) Device Market – MedCore
Coronary Introducer Sheath Market – MedCore
Coronary Vascular Closure Device (VCD) Market – MedCore
Diagnostic Coronary Catheter & Guidewire Market – MedCore
Intravascular Ultrasound (IVUS) Market – MedCore
Coronary Optical Coherency Tomography Catheter Market – MedCore

RESEARCH SCOPE SUMMARY

Regions: North America (United States and Canada), Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other), Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other), Central & Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other), Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other), Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.


executive summary
Global Interventional Cardiology Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Markets Included
Regions Included
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE global Interventional cardiology Market
2.1 Introduction
2.2 Regional Profiles
2.3 Analysis By Market Segment
2.3.1 Worst Case Scenario
2.3.2 Base Case Scenario
2.3.3 Best Case Scenario
Disease Overview
3.1 Basic Anatomy
3.2 Disease Treatment and Diagnostic
3.2.1 General Diagnostics
3.2.2 Coronary Artery Disease
3.2.3 Myocardial Infarction
3.2.4 Angina Pectoris
3.3 Patient Demographics
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Coronary Stent Market
4.2.2 Coronary Balloon Catheter Market
4.2.3 Interventional Coronary Catheter Market
4.2.4 Interventional Coronary Guidewire Market
4.2.5 Coronary Embolic Protection Device Market
4.2.5.1 Saphenous Vein Grafts
4.2.5.2 Protection Mechanism
4.2.5.2.1 Filter Basket
4.2.5.2.2 Distal Balloon Occlusion
4.2.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market
4.2.7 Introducer Sheath Market
4.2.8 Coronary Vascular Closure Device Market
4.2.9 Diagnostic Coronary Catheter & Guidewire Market
4.2.10 Coronary Intravascular Ultrasound Market
4.2.11 Coronary Optical Coherence Tomography Market
4.3 Regulatory Issues and Recalls
4.3.1 Coronary Stent Market FDA Recalls
4.3.2 Coronary Balloon Catheter Market FDA Recalls
4.3.3 Interventional Coronary Catheter Market FDA Recalls
4.3.4 Interventional Coronary Guidewire Market FDA Recalls
4.3.5 Coronary Atherectomy and Intravascular Lithotripsy Device Market FDA Recalls
4.3.6 Coronary Introducer Sheath Market FDA Recalls
4.3.7 Coronary Vascular Closure Device Market FDA Recalls
4.3.8 Diagnostic Coronary Catheter & Guidewire Market FDA Recalls
4.3.9 Coronary Intravascular Ultrasound Market FDA Recalls
4.4 Clinical Trials
4.4.1 Coronary Stent Market Clinical Trials
4.4.2 Coronary Balloon Catheter Market Clinical Trials
4.4.3 Interventional Coronary Catheter Market Clinical Trials
4.4.4 Interventional Coronary Guidewire Market Clinical Trials
4.4.5 Coronary Embolic Protection Device Market Clinical Trials
4.4.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market Clinical Trials
4.4.7 Coronary Vascular Closure Device
4.4.8 Coronary Intravascular Ultrasound
4.4.9 Coronary Optical Coherence Tomography
Global Interventional cardiology Device Market Overview
5.1 Introduction
5.1.1 Population at Risk
5.2 Market Overview & Trend Analysis
5.2.1 By Segment
5.2.2 By Region
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis
5.5 Mergers and Acquisitions
5.6 Company Profiles
5.6.1 Abbott
5.6.2 Asahi Intecc
5.6.3 Boston Scientific
5.6.4 Cook Medical
5.6.5 Cordis
5.6.6 Medtronic
5.6.7 Penumbra
5.6.8 Philips
5.6.9 Teleflex
5.6.10 Terumo
5.7 SWOT Analysis
5.7.1 Abbott
5.7.2 Asahi Intecc
5.7.3 Boston Scientific
5.7.4 Cordis
5.7.5 Cook Medical
5.7.6 Medtronic
5.7.7 Penumbra
5.7.8 Philips
5.7.9 Teleflex
5.7.10 Terumo
Coronary Stent Market
6.1 Executive Summary
6.1.1 Global Coronary Stent Market Overview
6.1.2 Competitive Analysis
6.1.3 Procedures Included
6.1.4 Markets Included
6.1.5 Regions Included
6.2 Introduction
6.3 Procedure Numbers
6.4 Market Overview
6.4.1 By Segment
6.4.2 By Region
6.5 Market Analysis and Forecast
6.5.1 Total Coronary Stent Market
6.5.2 Bare-Metal Stent Market
6.5.3 Drug-Eluting Stent Market
6.6 Drivers and Limiters
6.6.1 Market Drivers
6.6.2 Market Limiters
6.7 Competitive Market Share Analysis
Coronary Balloon Catheter Market
7.1 Executive Summary
7.1.1 Global Coronary Balloon Catheter Market Overview
7.1.2 Competitive Analysis
7.1.3 Procedures Included
7.1.4 Markets Included
7.1.5 Regions Included
7.2 Introduction
7.3 Procedure Numbers
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total Coronary Balloon Catheter Market
7.5.2 PTCA Balloon Catheter Market
7.5.3 Specialty Balloon Catheter Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis
interventional coronary catheter Market
8.1 Executive Summary
8.1.1 Global Interventional Coronary Catheter Market Overview
8.1.2 Competitive Analysis
8.1.3 Procedures Included
8.1.4 Regions Included
8.2 Introduction
8.3 Procedure Numbers
8.4 Market Analysis and Forecast
8.5 Drivers and Limiters
8.5.1 Market Drivers
8.5.2 Market Limiters
8.6 Competitive Market Share Analysis
Interventional Coronary guidewire Market
9.1 Executive Summary
9.1.1 Global Interventional Coronary Guidewire Market Overview
9.1.2 Competitive Analysis
9.1.3 Procedures Included
9.1.4 Regions Included
9.2 Introduction
9.3 Procedure Numbers
9.4 Market Analysis and Forecast
9.5 Drivers and Limiters
9.5.1 Market Drivers
9.5.2 Market Limiters
9.6 Competitive Market Share Analysis
Coronary embolic protection device Market
10.1 Executive Summary
10.1.1 Global Coronary Embolic Protection Device Market Overview
10.1.2 Competitive Analysis
10.1.3 Regions Included
10.2 Introduction
10.2.1 Protection Mechanism
10.2.1.1 Filter Basket
10.2.1.2 Distal Balloon Occlusion
10.3 Market Analysis and Forecast
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis
Atherectomy and Intravascular Lithotripsy Device Market
11.1 Executive Summary
11.1.1 Global Atherectomy and Intravascular Lithotripsy Device Market Overview
11.1.2 Competitive Analysis
11.1.3 Procedures Included
11.1.4 Regions Included
11.2 Introduction
11.3 Procedure Numbers
11.4 Market Analysis and Forecast
11.5 Drivers and Limiters
11.5.1 Market Drivers
11.5.2 Market Limiters
11.6 Competitive Market Share Analysis
Coronary Introducer Sheath Market
12.1 Executive Summary
12.1.1 Global Coronary Introducer Sheath Market Overview
12.1.2 Competitive Analysis
12.1.3 Procedures Included
12.1.4 Regions Included
12.2 Introduction
12.2.1 Introducer Sheaths
12.2.2 Micro-Introducers
12.2.3 Catheter Insertion Approaches
12.2.3.1 Femoral Approach
12.2.3.2 Radial/Brachial Approach
12.3 Procedure Numbers
12.4 Market Analysis and Forecast
12.5 Drivers and Limiters
12.5.1 Market Drivers
12.5.2 Market Limiters
12.6 Competitive Market Share Analysis
Coronary Vascular Closure Device Market
13.1 Executive Summary
13.1.1 Global Coronary Vascular Closure Device Market Overview
13.1.2 Competitive Analysis
13.1.3 Procedures Included
13.1.4 Markets Included
13.1.5 Regions Included
13.2 Introduction
13.2.1 Intravascular and Extravascular Devices
13.3 Procedure Numbers
13.4 Market Overview
13.4.1 By Segment
13.4.2 By Region
13.5 Market Analysis and Forecast
13.5.1 Total Coronary Vascular Closure Device Market
13.5.2 Invasive VCD Market
13.5.3 Non-Invasive VCD Market
13.6 Drivers and Limiters
13.6.1 Market Drivers
13.6.2 Market Limiters
13.7 Competitive Market Share Analysis
Diagnostic Catheter and Guidewire Market
14.1 Executive Summary
14.1.1 Global Diagnostic Catheter and Guidewire Market Overview
14.1.2 Competitive Analysis
14.1.3 Procedures Included
14.1.4 Markets Included
14.1.5 Regions Included
14.2 Introduction
14.3 Procedure Numbers
14.3.1 Total Procedures
14.3.2 Angiography Procedures
14.3.3 FFR Guidewire Procedures
14.4 Market Overview
14.4.1 By Segment
14.4.2 By Region
14.5 Market Analysis and Forecast
14.5.1 Total Diagnostic Catheter and Guidewire Market
14.5.2 Interventional Diagnostic Catheter Market
14.5.3 Interventional Diagnostic Guidewire Market
14.5.4 FFR Guidewire Market
14.6 Drivers and Limiters
14.6.1 Market Drivers
14.6.2 Market Limiters
14.7 Competitive Market Share Analysis
Optical Coherence Tomography Catheter Market
15.1 Executive Summary
15.1.1 Global Optical Coherence Tomography Catheter Market Overview
15.1.2 Competitive Analysis
15.1.3 Procedures Included
15.1.4 Regions Included
15.2 Introduction
15.2.1 OCT Applications
15.3 Procedure Numbers
15.4 Market Analysis and Forecast
15.5 Drivers and Limiters
15.5.1 Market Drivers
15.5.2 Market Limiters
15.6 Competitive Market Share Analysis
Intravascular Ultrasound Catheter Market
16.1 Executive Summary
16.1.1 Global Intravascular Ultrasound Catheter Market Overview
16.1.2 Competitive Analysis
16.1.3 Procedures Included
16.1.4 Regions Included
16.2 Introduction
16.2.1 Pre-Stenting Applications
16.2.2 Post-Stenting Applications
16.3 Procedure Numbers
16.4 Market Analysis and Forecast
16.5 Drivers and Limiters
16.5.1 Market Drivers
16.5.2 Market Limiters
16.6 Competitive Market Share Analysis
Abbreviations
List of Charts
Chart 1-1: Interventional Cardiology Market by Segment, Global, 2022 – 2029
Chart 1-2: Interventional Cardiology Procedures, Global, 2022 & 2029
Chart 2-1: Multi-Scenario Interventional Cardiology Market Forecast, Global, 2019 – 2029 (US$M)
Chart 5-1: Interventional Cardiology Market by Segment, Global, 2019 – 2029
Chart 5-2: Interventional Cardiology Market by Region, Global, 2019 – 2029
Chart 5-3: Leading Competitors, Interventional Cardiology Market, Global, 2022
Chart 6-1: Coronary Stent Market, Global, 2022 & 2029
Chart 6-2: Angioplasty/PCI Procedures, Global, 2022
Chart 6-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
Chart 6-4: Coronary Stent Market by Segment, Global, 2019 – 2022
Chart 6-5: Coronary Stent Market by Region, Global, 2019 – 2029
Chart 6-6: Leading Competitors, Coronary Stent Market, Global, 2022
Chart 7-1: Coronary Balloon Catheter Market, Global, 2022 & 2029
Chart 7-2: Angioplasty/PCI Procedures, Global, 2022
Chart 7-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
Chart 7-4: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029
Chart 7-5: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029
Chart 7-6: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022
Chart 8-1: Interventional Coronary Catheter Market, Global, 2022 & 2029
Chart 8-2: Angioplasty/PCI Procedures, Global, 2022
Chart 8-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
Chart 8-4: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022
Chart 9-1: Interventional Coronary Guidewire Market, Global, 2022 & 2029
Chart 9-2: Angioplasty/PCI Procedures, Global, 2022
Chart 9-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
Chart 9-4: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022
Chart 10-1: Coronary Embolic Protection Device Market, Global, 2022 & 2029
Chart 10-2: Coronary Embolic Protection Procedures, Global, 2022
Chart 10-3: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022
Chart 11-1: Atherectomy and IVL Device Market, Global, 2022 & 2029
Chart 11-2: Atherectomy and IVL Procedures, Global, 2022
Chart 11-3: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029
Chart 11-4: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022
Chart 12-1: Coronary Introducer Sheath Market, Global, 2022 & 2029
Chart 12-2: Coronary Introducer Sheath Procedures, Global, 2022
Chart 12-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
Chart 12-4: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022
Chart 13-1: Coronary Vascular Closure Device Market, Global, 2022 & 2029
Chart 13-2: Coronary Vascular Closure Device Procedures, Global, 2022
Chart 13-3: Catheterization Procedures by Region, Global, 2019 – 2029
Chart 13-4: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029
Chart 13-5: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029
Chart 13-6: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022
Chart 14-1: Diagnostic Catheter and Guidewire Market, Global, 2022 & 2029
Chart 14-2: Diagnostic Catheter and Guidewire Procedures, Global, 2022
Chart 14-3: Angiography Procedures by Region, Global, 2019 – 2029
Chart 14-4: FFR Guidewire Procedures by Region, Global, 2019 – 2029
Chart 14-5: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029
Chart 14-6: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029
Chart 14-7: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022
Chart 15-1: OCT Catheter Market, Global, 2022 & 2029
Chart 15-2: OCT Catheter Procedures, Global, 2022
Chart 15-3: OCT Procedures by Region, Global, 2019 – 2029
Chart 15-4: Leading Competitors, OCT Catheter Market, Global, 2022
Chart 16-1: IVUS Catheter Market, Global, 2022 & 2029
Chart 16-2: IVUS Catheter Procedures, Global, 2022
Chart 16-3: IVUS Procedures by Region, Global, 2019 – 2029
Chart 16-4: Leading Competitors, IVUS Catheter Market, Global, 2022
List of Figures
Figure 1-1: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (1 of 2)
Figure 1-2: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (2 of 2)
Figure 1-3: Companies Researched in This Report (1 of 2)
Figure 1-4: Companies Researched in This Report (2 of 2)
Figure 1-5: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (1 of 2)
Figure 1-6: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (2 of 2)
Figure 1-7: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (1 of 2)
Figure 1-8: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (2 of 2)
Figure 1-9: Interventional Cardiology Device Procedures Covered
Figure 1-10: Interventional Cardiology Device Markets Covered
Figure 1-11: Interventional Cardiology Device Market Regions Covered, Global (1 of 2)
Figure 1-12: Interventional Cardiology Device Market Regions Covered, Global (2 of 2)
Figure 1-13: Version History
Figure 2-1: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)
Figure 2-2: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)
Figure 2-3: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)
Figure 2-4: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)
Figure 2-5: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)
Figure 2-6: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)
Figure 4-1: Coronary Stents by Company
Figure 4-2: Coronary Balloon Catheters by Company
Figure 4-3: Interventional Coronary Catheters by Company
Figure 4-4: Interventional Coronary Guidewires by Company
Figure 4-5: Coronary Embolic Protection Devices by Company
Figure 4-6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company
Figure 4-7: Coronary Introducer Sheaths by Company (1 of 2)
Figure 4-8: Coronary Introducer Sheaths by Company (2 of 2)
Figure 4-9: Coronary Vascular Closure Devices by Company
Figure 4-10: Diagnostic Coronary Catheters & Guidewires by Company
Figure 4-11: Coronary Intravascular Ultrasound Devices by Company
Figure 4-12: Coronary Optical Coherence Tomography by Company
Figure 4-13: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System
Figure 4-14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm
Figure 4-15: Class 2 Device Recall Cordis Precise Nitinol Stent System
Figure 4-16: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System
Figure 4-17: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System
Figure 4-18: Class 1 Device Recall NC TREK Coronary Dilatation Catheter
Figure 4-19: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter
Figure 4-20: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters
Figure 4-21: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter
Figure 4-22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter
Figure 4-23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter
Figure 4-24: Class 2 Device Recall MAMBA Flex 135 Microcatheter
Figure 4-25: Class 2 Device Recall MAMBA Microcatheter
Figure 4-26: Class 2 Device Recall Guidezilla II Guide Extension Catheter
Figure 4-27: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER
Figure 4-28: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter
Figure 4-29: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
Figure 4-30: Class 1 Device Recall 6F Taiga Guiding Catheter
Figure 4-31: Class 2 Device Recall Destination Guiding Sheath
Figure 4-32: Class 2 Device Recall Stingray"" Guidewire
Figure 4-33: Class 1 Device Recall TurboHawk Plus
Figure 4-34: Class 1 Device Recall HawkOne
Figure 4-35: Class 2 Device Recall Boston Scientific ROTAPRO
Figure 4-36: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Figure 4-37: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER
Figure 4-38: Class 2 Device Recall
Figure 4-39: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification
Figure 4-40: Class 2 Device Recall Prelude Short Sheath Introducer
Figure 4-41: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer
Figure 4-42: Class 2 Device Recall Avanti Catheter Sheath Introducer
Figure 4-43: Class 1 Device Recall Flexor CheckFlo Introducer
Figure 4-44: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS
Figure 4-45: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER
Figure 4-46: Class 1 Device Recall Portico Solo ReCollapsible Access System
Figure 4-47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System
Figure 4-48: Class 2 Device Recall Microintroducer Kit
Figure 4-49: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices
Figure 4-50: Class 2 Device Recall AngioSeal Evolution
Figure 4-51: Class 1 Device Recall Imager II 5F Angiographic Catheter
Figure 4-52: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter
Figure 4-53: Class 2 Device Recall iLab Polaris MultiModality Guidance System
Figure 4-54: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN)
Figure 4-55: RESOLUTE ONYX China Single Arm Study
Figure 4-56: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)
Figure 4-57: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
Figure 4-58: PROMUS PREMIER™ China Post-Approval Study
Figure 4-59: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)
Figure 4-60: China Resolute Integrity 34/38 mm Study
Figure 4-61: ILUMIEN IV: OPTIMAL PCI
Figure 4-62: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
Figure 4-63: RESOLUTE ONYX Post-Approval Study (ONYX PAS)
Figure 4-64: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V)
Figure 4-65: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48)
Figure 4-66: Sirolimus DEB in Coronary Bifurcation Lesions
Figure 4-67: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)
Figure 4-68: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF)
Figure 4-69: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST)
Figure 4-70: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater
Figure 4-71: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I)
Figure 4-72: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease
Figure 4-73: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases
Figure 4-74: FIRE AND ICE II Trial Pilot
Figure 4-75: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD)
Figure 4-76: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First)
Figure 4-77: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI)
Figure 4-78: Pressure Guidewire Comparison
Figure 4-79: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2)
Figure 4-80: transShield Embolic Protection System Feasibility Study
Figure 4-81: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
Figure 4-82: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Figure 4-83: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s
Figure 4-84: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT)
Figure 4-85: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT)
Figure 4-86: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD)
Figure 4-87: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
Figure 4-88: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF)
Figure 4-89: Application of Vascular Closure Device in Transvenous Cardiac Intervention
Figure 4-90: Comparison of Different Vascular Closure Device in TAVI
Figure 4-91: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease
Figure 4-92: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE)
Figure 4-93: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
Figure 4-94: Vascular Closure Device in Transcatheter Aortic Valve Replacement
Figure 4-95: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
Figure 4-96: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES)
Figure 4-97: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
Figure 4-98: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
Figure 4-99: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER)
Figure 4-100: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS)
Figure 4-101: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP)
Figure 4-102: The OPTIMAL Randomized Controlled Trial
Figure 4-103: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite)
Figure 4-104: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES)
Figure 4-105: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS)
Figure 4-106: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB)
Figure 4-107: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography
Figure 4-108: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM)
Figure 4-109: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
Figure 5-1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2)
Figure 5-2: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2)
Figure 5-3: Interventional Cardiology Market by Region, Global, 2019 – 2029 (US$M)
Figure 5-4: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (1 of 2)
Figure 5-5: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (2 of 2)
Figure 5-6: SWOT Analysis, Abbott (1 of 2)
Figure 5-7: SWOT Analysis, Abbott (2 of 2)
Figure 5-8: SWOT Analysis, Asahi Intecc
Figure 5-9: SWOT Analysis, Boston Scientific
Figure 5-10: SWOT Analysis, Cordis
Figure 5-11: SWOT Analysis, Cook Medical
Figure 5-12: SWOT Analysis, Medtronic
Figure 5-13: SWOT Analysis, Penumbra
Figure 5-14: SWOT Analysis, Philips
Figure 5-15: SWOT Analysis, Teleflex
Figure 5-16: SWOT Analysis, Terumo
Figure 6-1: Coronary Stent Procedures Covered
Figure 6-2: Coronary Stent Markets Covered
Figure 6-3: Coronary Stent Regions Covered, Global (1 of 2)
Figure 6-4: Coronary Stent Regions Covered, Global (2 of 2)
Figure 6-5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
Figure 6-6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029
Figure 6-7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
Figure 6-8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
Figure 6-9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029
Figure 6-10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
Figure 6-11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
Figure 6-12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029
Figure 6-13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
Figure 6-14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
Figure 6-15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
Figure 6-16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029
Figure 6-17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M)
Figure 6-18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M)
Figure 6-19: Total Coronary Stent Market, Global, 2019 – 2029
Figure 6-20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029
Figure 6-21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$)
Figure 6-22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M)
Figure 6-23: Bare-Metal Stent Market, Global, 2019 – 2029
Figure 6-24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029
Figure 6-25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$)
Figure 6-26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M)
Figure 6-27: Drug-Eluting Stent Market, Global, 2019 – 2029
Figure 6-28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029
Figure 6-29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$)
Figure 6-30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M)
Figure 6-31: Leading Competitors, Coronary Stent Market, Global, 2022
Figure 7-1: Coronary Balloon Catheter Procedures Covered
Figure 7-2: Coronary Balloon Catheter Markets Covered
Figure 7-3: Coronary Balloon Catheter Regions Covered, Global (1 of 2)
Figure 7-4: Coronary Balloon Catheter Regions Covered, Global (2 of 2)
Figure 7-5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
Figure 7-6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029
Figure 7-7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
Figure 7-8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
Figure 7-9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029
Figure 7-10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
Figure 7-11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
Figure 7-12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings